New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 27, 2014
08:21 EDTAFFX, DDXS, FLDM, PACB, PKI, SQNM, WATMaxim recommends life science tools, diagnostics ahead of earnings
Maxim expects 2014 to be a "great year" for life science tools and diagnostics stocks and recommends buying Affymetrix (AFFX), diaDexus (DDXS), Fluidigm (FLDM), Pacific Biosciences (PACB), PerkinElmer (PKI), Sequenom (SQNM) and Waters (WAT) ahead of the Q4 results. Maxim has a preference for Pacific Biosciences, PerkinElmer and Waters. The firm raised its price target for Fluidigm to $52 from $42 and for Pacific Biosciences to $9 from $8.
News For AFFX;DDXS;FLDM;PACB;PKI;SQNM;WAT From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 20, 2014
15:36 EDTWATNotable companies reporting before tomorrow's open
Subscribe for More Information
07:10 EDTPKI, AFFX, FLDMAmerican Society of Human Genetics to hold annual meeting
Subscribe for More Information
06:32 EDTAFFXAffymetrix licenses Peptide Groove technology
Subscribe for More Information
October 16, 2014
06:32 EDTAFFXAffymetrix and Ariosa Diagnostics sign multi-year prenatal test supply agreement
Subscribe for More Information
October 15, 2014
07:43 EDTPACBPacific Biosciences releases new enhancing DNA sequencing chemistry
Subscribe for More Information
October 7, 2014
12:35 EDTDDXSdiaDexus downgraded to Neutral from Buy at Ladenburg
Ladenburg downgraded diaDexus to Neutral citing limited visibility and concerns about its Q3 results.
10:18 EDTSQNMHigh option volume stocks
Subscribe for More Information
09:24 EDTSQNMMaxim recommends buying Sequenom
Subscribe for More Information
09:01 EDTSQNMSequenom acquisition a strategic positive, says Maxim
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use